SCHEMBL9963586

SCHEMBL9963586

CCS(=O)(=O)N1CCN(C(=O)CNc2nc3c(C)c4nc(NCC(=O)N5CCCCC5)sc4cc3s2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.44
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
LMNA P02545 4/20 0.39
HTT P42858 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPK1 P28482 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
POLB P06746 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 2/20 0.37
FABP4 P15090 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PRMT3 O60678 1/20 0.36
RAB9A P51151 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963553 0.87 PTGS2 (0.47) PTGS2ALDH1A1MAPTMAPK1TP53
SCHEMBL9963526 0.87 PTGS2 (0.47) PTGS2ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL9963545 0.86 PTGS2 (0.51) PTGS2ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL9963695 0.85 PTGS2 (0.49) PTGS2ALDH1A1MAPTKDM4EFABP4
SCHEMBL9963584 0.84 PTGS2 (0.51) PTGS2ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL9963593 0.84 PTGS2 (0.46) PTGS2ALDH1A1MAPTKDM4EFABP4
SCHEMBL9963484 0.83 PTGS2 (0.45) PTGS2ALDH1A1SMN1; SMN2KDM4EFABP4
SCHEMBL9963479 0.83 PTGS2 (0.45) PTGS2ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL9963585 0.83 BCHE (0.45) PTGS2ALDH1A1MAPTMEN1KMT2A
SCHEMBL9963555 0.82 PTGS2 (0.42) PTGS2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 PTGS2 2872/4885ALDH1A1 51/4885SMN1; SMN2 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.